Since intracellular zinc levels are mainly controlled by zinc transporter ZIP1, we then examined the expression profiles of ERRα, ACO2 and ZIP1 in clinical prostate cancer samples using an available prostate cancer dataset. Here, SLC39A1 is linked to prostate carcinoma.